- Home
- / Race Oncology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Race Oncology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.2
2024-10-29
Market Capitalization
$208 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 170.0K | 229.0K | 256.0K | 425.0K | 708.0K | 3.1M | 4.0M | 5.3M |
| Operating expense total | 6.2M | 3.6M | 3.8M | 6.5M | 11.7M | 13.4M | 18.4M | 10.5M |
| Depreciation and amortization | 251.0K | 281.0K | 281.0K | 281.0K | 281.0K | 281.0K | 281.0K | 281.0K |
| EBITDA | (6.1M) | (3.4M) | (3.6M) | (6.1M) | (11.0M) | (10.2M) | (14.4M) | (5.3M) |
| EBIT | (6.3M) | (3.7M) | (3.9M) | (6.4M) | (11.3M) | (10.5M) | (14.7M) | (5.6M) |
| Interest income | 22.0K | 17.0K | 9.0K | 19.0K | 54.0K | 592.0K | 833.0K | 788.0K |
| Pre tax profit | (6.3M) | (3.7M) | (3.8M) | (6.3M) | (11.2M) | (9.9M) | (13.8M) | (4.8M) |
| Net Income | (6.3M) | (3.7M) | (3.8M) | (6.3M) | (11.2M) | (9.9M) | (13.8M) | (4.8M) |